121 related articles for article (PubMed ID: 34191062)
1. Cumulative Intracranial Tumor Volume as a Prognostic Factor in Patients with Brain Metastases Undergoing Stereotactic Radiosurgery.
Hirshman BR; Compton J; Carroll KT; Ali MA; Wang SG; Chen CC
Acta Neurochir Suppl; 2021; 128():57-69. PubMed ID: 34191062
[TBL] [Abstract][Full Text] [Related]
2. Improving the Prognostic Value of Disease-Specific Graded Prognostic Assessment Model for Renal Cell Carcinoma by Incorporation of Cumulative Intracranial Tumor Volume.
Ali MA; Hirshman BR; Wilson B; Schupper AJ; Joshi R; Proudfoot JA; Goetsch SJ; Alksne JF; Ott K; Aiyama H; Nagano O; Carter BS; Chiang V; Serizawa T; Yamamoto M; Chen CC
World Neurosurg; 2017 Dec; 108():151-156. PubMed ID: 28754641
[TBL] [Abstract][Full Text] [Related]
3. Robustness of the neurological prognostic score in brain metastasis patients treated with Gamma Knife radiosurgery.
Serizawa T; Higuchi Y; Nagano O; Matsuda S; Aoyagi K; Ono J; Saeki N; Iwadate Y; Hirai T; Takemoto S; Shibamoto Y
J Neurosurg; 2017 Nov; 127(5):1000-1006. PubMed ID: 27911235
[TBL] [Abstract][Full Text] [Related]
4. Cumulative intracranial tumour volume prognostic assessment: a new predicting score index for patients with brain metastases treated by stereotactic radiosurgery.
Donofrio CA; Cavalli A; Gemma M; Riccio L; Donofrio A; Panni P; Ferrari da Passano C; Del Vecchio A; Bolognesi A; Soffietti R; Mortini P
Clin Exp Metastasis; 2020 Aug; 37(4):499-508. PubMed ID: 32430649
[TBL] [Abstract][Full Text] [Related]
5. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
Kano H; Morales-Restrepo A; Iyer A; Weiner GM; Mousavi SH; Kirkwood JM; Tarhini AA; Flickinger JC; Lunsford LD
J Neurosurg; 2018 Jan; 128(1):14-22. PubMed ID: 28106495
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Importance of Cumulative Intracranial Tumor Volume in Patients with Gastrointestinal Brain Metastasis Treated with Stereotactic Radiosurgery.
Joshi RS; Hirshman BR; Ali MA; Alattar A; Carroll K; Nagano O; Aiyama H; Serizawa T; Yamamoto M; Chen CC
World Neurosurg; 2019 Jan; 121():e747-e754. PubMed ID: 30308343
[TBL] [Abstract][Full Text] [Related]
7. Superior Prognostic Value of Cumulative Intracranial Tumor Volume Relative to Largest Intracranial Tumor Volume for Stereotactic Radiosurgery-Treated Brain Metastasis Patients.
Hirshman BR; Wilson B; Ali MA; Proudfoot JA; Koiso T; Nagano O; Carter BS; Serizawa T; Yamamoto M; Chen CC
Neurosurgery; 2018 Apr; 82(4):473-480. PubMed ID: 28658940
[TBL] [Abstract][Full Text] [Related]
8. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases.
Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y
J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935
[TBL] [Abstract][Full Text] [Related]
9. Cumulative Intracranial Tumor Volume (CITV) Enhances the Prognostic Value of the Lung-Specific Graded Prognostic Assessment (GPA) Model.
Marcus LP; Marshall D; Hirshman BR; McCutcheon BA; Gonda DD; Koiso T; Hattangadi-Gluth JA; Carter BS; Yamamoto M; Chen CC
Neurosurgery; 2016 Aug; 79(2):246-52. PubMed ID: 26579964
[TBL] [Abstract][Full Text] [Related]
10. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
[TBL] [Abstract][Full Text] [Related]
11. Cumulative Intracranial Tumor Volume Augments the Prognostic Value of Diagnosis-Specific Graded Prognostic Assessment Model for Survival in Patients with Melanoma Cerebral Metastases.
Hirshman BR; Wilson BR; Ali MA; Schupper AJ; Proudfoot JA; Goetsch SJ; Carter BS; Sinclair G; Bartek J; Chiang V; Fogarty G; Hong A; Chen CC
Neurosurgery; 2018 Aug; 83(2):237-244. PubMed ID: 28973506
[TBL] [Abstract][Full Text] [Related]
12. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of upfront stereotactic radiosurgery for brain metastases with high cumulative intracranial tumor volume (> 7 ml): analysis of 233 consecutive patients.
Yomo S; Oda K; Oguchi K
Acta Neurochir (Wien); 2021 Apr; 163(4):991-1001. PubMed ID: 33398539
[TBL] [Abstract][Full Text] [Related]
14. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
15. Validity of prognostic grading indices for brain metastasis patients undergoing repeat radiosurgery.
Yamamoto M; Kawabe T; Higuchi Y; Sato Y; Nariai T; Watanabe S; Barfod BE; Kasuya H
World Neurosurg; 2014 Dec; 82(6):1242-9. PubMed ID: 25109592
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of prognostic scoring systems in patients with brain metastases treated with radiosurgery.
Zindler JD; Rodrigues G; Haasbeek CJ; De Haan PF; Meijer OW; Slotman BJ; Lagerwaard FJ
Radiother Oncol; 2013 Mar; 106(3):370-4. PubMed ID: 23522151
[TBL] [Abstract][Full Text] [Related]
17. Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study.
Rice SR; Bentzen SM; Hanna A; Choi E; Boggs DH; Kwok Y; Hyder J; Feigenberg SJ; Regine WF; Woodworth GF; Eisenberg HM; Yu C; Biggins TF; Barnholtz-Sloan JS; Sperduto PW; Weltman E; Mehta MP
J Neurooncol; 2018 Nov; 140(2):341-349. PubMed ID: 30132164
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Prognostic Indices in NSCLC Patients with Brain Metastases after Radiosurgery.
Gao HX; Huang SG; Du JF; Zhang XC; Jiang N; Kang WX; Mao J; Zhao Q
Int J Biol Sci; 2018; 14(14):2065-2072. PubMed ID: 30585269
[TBL] [Abstract][Full Text] [Related]
20. An integrated disease-specific graded prognostic assessment scale for melanoma: contributions of KPS, CITV, number of metastases, and BRAF mutation status.
Ahluwalia M; Ali MA; Joshi RS; Park ES; Taha B; McCutcheon I; Chiang V; Hong A; Sinclair G; Bartek J; Chen CC
Neurooncol Adv; 2021; 3(1):vdaa152. PubMed ID: 33506199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
